NYSE: AREAlexandria Real Estate Equities Inc Stock
$51.60+0.87 (+1.71%)
Updated Jun 23, 2026
ARE Price
$51.60
Fair Value Price
N/A
Market Cap
$8.99B
52 Week Low
$39.41
52 Week High
$88.24
P/E
-8.23x
P/B
0.57x
P/S
2.74x
PEG
N/A
Dividend Yield
5.35%
Revenue
$2.94B
Earnings
-$1.06B
Gross Margin
68.7%
Operating Margin
-27.85%
Profit Margin
-36.3%
Debt to Equity
0.94
Operating Cash Flow
$1B
Beta
0.93
Next Earnings
Aug 3, 2026
Ex-Dividend
Jun 30, 2026
Next Dividend
Jul 15, 2026
ARE Overview
Alexandria Real Estate Equities, Inc. is a real estate investment trust (REIT) that invests in office buildings and laboratories leased to tenants in the life science and technology industries. The company also has a venture capital arm, Alexandria Venture Investments, which invests in life sciences firms. The company was founded in 1994 and is headquartered in Pasadena, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine ARE's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Office REIT
Industry Rating
F
ARE
Ranked#10 of 19
Ranked#10 of 19
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $23.43 | C | |
| $11.45 | C | |
| $29.53 | C |
Be the first to know about important ARE news, forecast changes, insider trades & much more!
ARE News
Overview
Due Diligence Score
–
Industry Average (16)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how ARE scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
ARE is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ARE is good value based on its book value relative to its share price (0.57x), compared to the US REIT - Office industry average (0.94x)
P/B vs Industry Valuation
ARE is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more ARE due diligence checks available for Premium users.
Valuation
ARE price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-8.23x
Industry
-74.87x
Market
7.68x
ARE price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.57x
Industry
0.94x
ARE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
ARE's financial health
Profit margin
Revenue
$671.0M
Net Income
$361.7M
Profit Margin
53.5%
ARE's Earnings (EBIT) of -$818.57M... subscribe to Premium to read more.
Interest Coverage Financials
ARE's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$34.2B
Liabilities
$14.8B
Debt to equity
0.94
ARE's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
ARE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$196.6M
Investing
-$584.8M
Financing
$258.0M
ARE's operating cash flow ($1.40B)... subscribe to Premium to read more.
Debt Coverage Financials
ARE vs Office REIT Stocks
Alexandria Real Estate Equities Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.